IP Library › Assignment 059832/0335
Patent Assignment
Reel/Frame 059832/0335

Assignment of Assignor's Interest

Recorded: 2022-05-05 Pages: 3
Assignors
LEBIODA, KENNETH EUGENE
Executed: 2020-03-11
KHAN, AZIZ NAEEM
Executed: 2020-03-11
Assignee
RESVERLOGIX CORP.
300, 4820 RICHARD ROAD, SW, CALGARY, ALBERTA, T3E 6L1, CANADA
Covered Property (1)
Methods of Treatment and/or Prevention of Major Adverse Cardiovascular Events (Mace) with a Combination of a Bet Bromodomain Inhibitor and a Sodium Dependent Glucose Transport 2 Inhibitor
Application: 17/774,657 →
Publication: US 2022/0370452